00 days 00 hours 00 min 00 sec

We will be at Hospitalar 2026. Shall we talk?

Latin America's largest healthcare trade fair, with 1,250+ exhibitors, 90,000+ visitors from 70+ countries in 4 days at Expo Imigrantes in São Paulo. The HSC team at stand E-149, shared with Anbiotec, is ready to discuss your regulatory project.

Event
Shared stand
  • 19-22 May Dates
  • Expo Imigrantes Venue in São Paulo
  • E-149 Anbiotec stand
  • PT, EN, ES Languages

3 challenges we solve.

Multi-jurisdictional complexity

Every market has its own authority, framework and timeline. Coordinating simultaneous registrations requires a methodology, rather than improvisation.

  • ANVISA, FDA, EU MDR, MDSAP
  • Synchronised regulatory schedules
  • Cross-country requirements
  • A gateway strategy for each market

Critical deadline pressure

EUDAMED on 28 May 2026, the QMSR/FDA transition and new ANVISA resolutions. Regulatory windows do not wait.

  • EUDAMED delivery in May 2026
  • FDA QMSR already in force
  • Ongoing ANVISA updates
  • MDSAP audit every 3 years

Your regulatory direction, defined.

We work in two directions: bringing global manufacturers into Brazil and taking Brazilian companies to international markets. Choose your route.

Inbound Global Brazil

Enter Brazil

For manufacturers from China, India, South Korea, Europe and the USA needing to register medical devices in Brazil. We manage the entire process as your local Registration Holder (BRH) and Importer of Record (IOR), from the modular technical dossier to ANVISA registration under RDC 751.

Start your market entry
Outbound Brazil Global

Reach the world

For Brazilian manufacturers ready to expand internationally. We structure your ISO 13485:2016 quality system and dossiers for FDA QMSR, EU MDR/IVDR and the MDSAP audit covering five regulated markets in a single certification.

Start your expansion

ANVISA Registration

From notification to full registration under RDC 751. Modular technical dossiers, GMP and risk classification for all Classes I to IV.

MDSAP, FDA, EU MDR

Five markets in one MDSAP certification. The audit covers Brazil, the USA, Canada, Australia and Japan, with additional support for FDA QMSR and EU MDR 2017/745.

ISO 13485 and QMS

An end-to-end quality system. ISO 13485:2016 implementation aligned with RDC 665, with a pre-certification internal audit.

BRH + IOR in Brazil

Your local Registration Holder (BRH) and Importer of Record (IOR) for entering the Brazilian market without establishing your own CNPJ.

Who you will meet.

The HSC team will be present throughout all 4 days. Decision-making, bilingual support and technical depth in a single conversation.

Photo of Nicolas Crispim

Nicolas Crispim

CEO and founder

Exemplar Global MDSAP RTP. Former BSI Lead Auditor.

Photo of Rafael

Rafael

Business Development

Leads HSC's international expansion. A strategic link between global manufacturers and ANVISA registration.

Photo of Mariana Barreira

Mariana Barreira

MDSAP Lead Auditor

Technical depth for regulatory questions on the spot.

Booking

Book your meeting at the stand.

30-minute slots, with direct access to our regulatory specialists.